Presentations

Presentations

OMIDRIA Manuscripts

Date Title Citation Author
2/18 Effect of Phenylephrine/Ketorolac on Iris Fixation Ring Use and Surgical Times in Patients at Risk of Intraoperative Miosis Clin Ophthalmol. 2018;12:301-305 Visco
12/17 Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery Clin Ophthalmol. 2018;12:21-28 Rosenberg
8/17 Effect of Early Phenylephrine and Ketorolac Injection 1%/0.3% (Omidria ®) Usage on Pupil Diameter in Traditional and Femto-Assisted Cataract Surgery Abstract with Poster presentation at: 15th International Congress on Vision Science and Eye Gayton
10/17 Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration Clin Ophthalmol. 2017:11 1897–1901 Katsev
  Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model JOPT. 2018; 34:154-160 Waterbury
6/17 Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery JCRS 2017; 43: 597-605 Donnenfeld
6/17 Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery Clin Ophthalmol. 2017; 11: 1039-1043 Bucci
5/17 Importance of pupil dilation for cataract surgery JCRS Editorial; Volume 43 Issue 5 May 2017 Mammalis
12/16 Letter to the Editor: An Alternative to Topical Dosing to Deliver Drugs to Target Tissues JOPT. 2016; 10: 1-2 Waterbury
9/16 Patient considerations in cataract surgery – the role of combined therapy using phenylephrine and ketorolac Patient Preference and Adherence 2016; 10: 1795-1801 Gonzalez-Salinas
2/16 Becoming a Believer February 2016 | Cataract & Refractive Surgery Today Walter
10/15 Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies J Cataract Refract Surg. 2015; 41: 2060- 2068 Hovanesian
7/15 The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery Clin Ophthalmol. 2015; 9: 1249-1254 Lawuyi
4/15 Point/Counterpoint: A Disruptive Innovation or a Costly Disruption? April 2015 | Cataract & Refractive Surgery Today Donnenfeld / Walter
3/15 OMS302 (phenylephrine and ketorolac injection) 1%/0.3% to maintain intraoperative pupil size and to prevent postoperative ocular pain in cataract surgery with intraocular lens replacement Expert Rev. Ophthalmol. 2015; 10(2): 91–103 Osher
9/14 Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsification Clin Ophthalmol. 2014; 8: 1735-1744 Lindstrom
7/14 Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions Clin Ophthalmol. 2014; 8: 1281-1289 Grob

OMS721 Posters

Date Meeting Title Author
11/17 American Society of Nephrology Maintenance of Remission Following Completion of OMS721 Treatment in Patients with IgA Nephropathy (IGAN) Block
10/17 European Society for Blood and Marrow Transplantation - Crash Course on Diagnosis and Treatment of Noninfectious Complications after HCT Effective Treatment of GvHD-Associated Transplant-Associated Microangiopathy with a Novel Inhibitor of the Lectin Pathway of Complement Caprioli
06/17 54th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress The Effect of OMS721 on Proteinuria in Patients with IgA Nephropathy Block
04/17 International Society of Nephrology (ISN) World Congress of Nephrology Dose-Finding Clinical Trial of OMS721 for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS) – Stage 1 Results Nowicki
03/17 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation Resolution of acute kidney injury secondary to TA-TMA by the anti-MASP-2 monoclonal antibody OMS721 in a pediatric HSCT recipient Zecca
02/17 2017 Tandem Meeting of the American Society of Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA) Khaled